Company intelligence / Profile preview

Vital Neuro

Ownership: Private
Development stage: Commercial

Overview

Vital Neuro has commercialized a patented wearable EEG device for non-invasive brain training. The company reports successful six-week trials with over 50,000 sessions among high-stress professionals. Self-reported outcomes include improvements in anxiety levels, sleep quality, concentration/focus, energy levels, and overall well-being. Protocols are supported by a large dataset (>75k sessions) but no formal clinical trial data or peer-reviewed publications are cited on their website.

Therapeutic areas: PsychiatryNeurology
Modalities: DeviceNon-pharmacological therapy (neurofeedback)Digital therapeutic (EEG-based neurofeedback and audio intervention)
Industry: Physiological Monitoring

Beyond the preview

Go deeper on Vital Neuro.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vital Neuro.

Explore the full profile